Skip to content
PubMed This is a summary of 32 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 32 referenced papers

Top Authors

Manoj P. Menezes
The University of Sydney
Alagarraju Muthukumar
The University of Texas Southwestern Medical Center
Isabelle Desguerre
Hôpital Necker-Enfants Malades
Cyril Gitiaux
Hôpital Necker-Enfants Malades
Dominique Roland
Institute of Pathology and Genetics
Periyasamy Radhakrishnan
Manipal Academy of Higher Education
Sheela Nampoothiri
Amrita Institute of Medical Sciences and Research Centre
Joseph P. Dewulf
Cliniques Universitaires Saint-Luc

Top Institutions

Ranked by publications Top 10 institutions
01
03
08

Université de Lille

Lille, France

3 papers
09

Manipal Academy of Higher Education

Manipal, India

2 papers
10

Amrita Institute of Medical Sciences and Research Centre

Ernakulam, India

2 papers

References

References (32)
  1. 1

    Major involvement of Na(+) -dependent multivitamin transporter (SLC5A6/SMVT) in uptake of biotin and pantothenic acid by human brain capillary endothelial cells.

    Uchida Y, Ito K, Ohtsuki S, et al.

    Journal of neurochemistry 2015; (134(1)):97-112 doi:10.1111/jnc.13092.

    PMID: 25809983
  2. 2

    Genotype/phenotype correlations in AARS-related neuropathy in a cohort of patients from the United Kingdom and Ireland.

    Bansagi B, Antoniadi T, Burton-Jones S, et al.

    Journal of neurology 2015; (262(8)):1899-908 doi:10.1007/s00415-015-7778-4.

    PMID: 26032230
  3. 3

    Clinical presentation and outcome of riboflavin transporter deficiency: mini review after five years of experience.

    Jaeger B, Bosch AM

    Journal of inherited metabolic disease 2016; (39(4)):559-64 doi:10.1007/s10545-016-9924-2.

    PMID: 26973221
  4. 4

    PLA2G6-associated neurodegeneration: Lessons from neurophysiological findings.

    Gitiaux C, Kaminska A, Boddaert N, et al.

    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2018; (22(5)):854-861 doi:10.1016/j.ejpn.2018.05.005.

    PMID: 29859652
  5. 5

    Genetic, Radiologic, and Clinical Variability in Brown-Vialetto-van Laere Syndrome.

    Woodcock IR, Menezes MP, Coleman L, et al.

    Seminars in pediatric neurology 2018; (26()):2-9 doi:10.1016/j.spen.2017.03.001.

    PMID: 29961509
  6. 6

    Comprehensive assessment of biotin interference in immunoassays.

    Li J, Wagar EA, Meng QH

    Clinica chimica acta; international journal of clinical chemistry 2018; (487()):293-298 doi:10.1016/j.cca.2018.10.013.

    PMID: 30296442
  7. 7

    Susceptibility of Cardiac Troponin Assays to Biotin Interference.

    Frame IJ, Joshi PH, Mwangi C, et al.

    American journal of clinical pathology 2019; (151(5)):486-493 doi:10.1093/ajcp/aqy172.

    PMID: 30715102
  8. 8

    Genetic defect of the sodium-dependent multivitamin transporter: A treatable disease, mimicking biotinidase deficiency.

    Schwantje M, de Sain-van der Velden M, Jans J, et al.

    JIMD reports 2019; (48(1)):11-14 doi:10.1002/jmd2.12040.

    PMID: 31392107
  9. 9

    Best practices in mitigating the risk of biotin interference with laboratory testing.

    Bowen R, Benavides R, Colón-Franco JM, et al.

    Clinical biochemistry 2019; (74()):1-11 doi:10.1016/j.clinbiochem.2019.08.012.

    PMID: 31473202
  10. 10

    Interference From High-Dose Biotin Intake in Immunoassays for Potentially Time-Critical Analytes by Roche.

    Mrosewski I, Urbank M, Stauch T, Switkowski R

    Archives of pathology & laboratory medicine 2020; (144(9)):1108-1117 doi:10.5858/arpa.2019-0425-OA.

    PMID: 31944861
  11. 11

    A survey-based study of physician practices regarding biotin supplementation.

    Waqas B, Wu A, Yim E, Lipner SR

    The Journal of dermatological treatment 2022; (33(1)):573-574 doi:10.1080/09546634.2020.1770178.

    PMID: 32419559
  12. 12

    AACC Guidance Document on Biotin Interference in Laboratory Tests.

    Li D, Ferguson A, Cervinski MA, et al.

    The journal of applied laboratory medicine 2020; (5(3)):575-587 doi:10.1093/jalm/jfz010.

    PMID: 32445355
  13. 13

    Sense and nonsense concerning biotin interference in laboratory tests.

    Moerman A, Delanghe JR

    Acta clinica Belgica 2022; (77(1)):204-210 doi:10.1080/17843286.2020.1780770.

    PMID: 32567529
  14. 14

    Biotin Interference in Assays for Thyroid Hormones, Thyrotropin and Thyroglobulin.

    Ylli D, Soldin SJ, Stolze B, et al.

    Thyroid : official journal of the American Thyroid Association 2021; (31(8)):1160-1170 doi:10.1089/thy.2020.0866.

    PMID: 34042535
  15. 15

    Novel biallelic variants expand the SLC5A6-related phenotypic spectrum.

    Holling T, Nampoothiri S, Tarhan B, et al.

    European journal of human genetics : EJHG 2022; (30(4)):439-449 doi:10.1038/s41431-021-01033-2.

    PMID: 35013551
  16. 16

    Biotinidase deficiency: What have we learned in forty years?

    Tankeu AT, Van Winckel G, Elmers J, et al.

    Molecular genetics and metabolism 2023; (138(4)):107560 doi:10.1016/j.ymgme.2023.107560.

    PMID: 37027963
  17. 17

    A novel SLC5A6 homozygous variant in a family with multivitamin-dependent neurometabolic disorder: Phenotype expansion and long-term follow-up.

    Montomoli M, Vetro A, Tubili F, et al.

    European journal of medical genetics 2023; (66(8)):104808 doi:10.1016/j.ejmg.2023.104808.

    PMID: 37391029
  18. 18

    Sodium-dependent multivitamin transporter defects: a rare cause of recurrent vomiting and faltering growth.

    Rupasinghe K, Onyeador N

    Frontline gastroenterology 2023; (14(4)):346-349 doi:10.1136/flgastro-2022-102344.

    PMID: 37409333
  19. 19

    Novel missense variants cause intermediate phenotypes in the phenotypic spectrum of SLC5A6-related disorders.

    Utsuno Y, Hamada K, Hamanaka K, et al.

    Journal of human genetics 2024; (69(2)):69-77 doi:10.1038/s10038-023-01206-5.

    PMID: 38012394
  20. 20

    Recurrent "outsider" intronic variation in the SLC5A6 gene causes severe mixed axonal and demyelinating neuropathy, cyclic vomiting and optic atrophy in 3 families from Maghreb.

    Mansour-Hendili L, Gitiaux C, Harion M, et al.

    Frontiers in genetics 2024; (15()):1352006 doi:10.3389/fgene.2024.1352006.

    PMID: 38348452
  21. 21

    A new case of sodium-dependent multivitamin transporter defect occurring as a life-threatening condition responsive to early vitamin supplementation and literature review.

    Van Vyve FX, Mercier N, Papadopoulos J, et al.

    Molecular genetics & genomic medicine 2024; (12(2)):e2388 doi:10.1002/mgg3.2388.

    PMID: 38407570
  22. 22

    Genome sequencing enables diagnosis and treatment of SLC5A6 neuropathy.

    Riley LG, Sabui S, Said HM, et al.

    European journal of human genetics : EJHG 2024; (32(8)):947-953 doi:10.1038/s41431-024-01641-8.

    PMID: 38816490
  23. 23

    Biotin Homeostasis and Human Disorders: Recent Findings and Perspectives.

    Karachaliou CE, Livaniou E

    International journal of molecular sciences 2024; (25(12)) doi:10.3390/ijms25126578.

    PMID: 38928282
  24. 24

    Molecular Mechanisms of Biotin in Modulating Inflammatory Diseases.

    Sakurai-Yageta M, Suzuki Y

    Nutrients 2024; (16(15)) doi:10.3390/nu16152444.

    PMID: 39125325
  25. 25

    Expanded Clinical Phenotype and the Role of Untargeted Metabolomics Analysis in Confirming the Diagnosis of Sodium-Dependent Multivitamin Transporter Deficiency.

    Walimbe AS, Waskow E, Mackay L, et al.

    American journal of medical genetics. Part A 2025; (197(6)):e64014 doi:10.1002/ajmg.a.64014.

    PMID: 39898461
  26. 26

    Prenatal Brain Abnormalities in Sodium-Dependent Multivitamin Transporter Deficiency.

    Ogawa E, Kosaki K, Takenouchi T

    American journal of medical genetics. Part A 2025; (197(9)):e64102 doi:10.1002/ajmg.a.64102.

    PMID: 40272030
  27. 27

    SLC5A6 Mutations in Axonal Sensorimotor Polyneuropathy Patients Concurrent With Sodium Dependent Multivitamin Transporter Deficiency and Improved Effects by Multivitamin Therapy.

    Pi BK, Lee AJ, Nam SH, et al.

    Journal of the peripheral nervous system : JPNS 2025; (30(2)):e70030 doi:10.1111/jns.70030.

    PMID: 40396389
  28. 28

    A Slc5a6-deficient mouse model reveals metabolically driven cardiomyopathy with therapeutic potential for vitamin-based intervention.

    Fullerton MO, Phillips LC, Redgrave RE, et al.

    JCI insight 2026; (11(14)).

    PMID: 42228401
  29. 29

    Structural basis for multivitamin recognition and transport by human SMVT.

    Zhen Q, Wang M, Zhang Z

    Nature communications 2026; (17(1)).

    PMID: 42364996
  30. 30

    An Optimized Diagnostic Approach for Adults With Suspected Inherited Metabolic Disorders.

    Oud MM, Ferreira EA, van Karnebeek CDM, et al.

    Journal of inherited metabolic disease 2026; (49(5)):e70238 doi:10.1002/jimd.70238.

    PMID: 42625355
  31. 31

    Sodium-dependent multivitamin transporter deficiency caused by novel SLC5A6 mutations: a clinical case and personalized mice model study.

    Priymak AV, Averina OA, Novikova MA, et al.

    Frontiers in cell and developmental biology 2026; (14()):1925753 doi:10.3389/fcell.2026.1925753.

    PMID: 42920491
  32. 32

    The implications of biotin supplementation on multiple sclerosis, hair loss conditions, and thyroid disorders.

    Bhimireddy N, Na S, Cho E

    Multiple sclerosis and related disorders 2026; (116()):107974 doi:10.1016/j.msard.2026.107974.

    PMID: 42933321